Data: 08/08/2026
Total encontrado: 6
1/6US=4 / Cirurgia
Chung CT. Preoperative chemotherapy for locally advanced and inflammatory breast cancer. In: Silberman H, Silberman AW. Principles and practice of surgical oncology: a multidisciplinary approach to difficult problems. Philadelphia: J B Lippincott, 2010. p. 452-71. ISBN 978-0-7817-6546-6.

CANCER; ONCOLOGIA CIRURGICA; CANCER DE MAMA; QUIMIOTERAPIA PRE-OPERATORIA; CANCER DE MAMA LOCALMENTE AVANCADO; CANCER DE MAMA INFLAMATORIO; QUIMIOTERAPIA COM TAXANO; TRASTUZUMABE

2/6US=21 / Biol/Mol
Carré M, Braguer D. Microtubule damaging agents and apoptosis. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 479-518. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

AGENTES NOCIVOS MICROTUBULOS E APOPTOSE; APOPTOSE; MITOCONDRIAS; MICROTUBULOS; CELULA TUMORAL; DROGAS ANTI-CANCER; TAXANO; VINCA ALCALOIDES

3/6US=23 / Câncer
Pallis AG, Georgoulias V, Mavroudis V. Advanced breast cancer: treatment with docetaxel/epirubicin. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 361-71. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA AVANCADO; CANCER DE MAMA. TRATAMENTO; DOCETAXEL; EPIRRUBICINA; COMBINACAO ANTRACICLINA-TAXANO; COMBINACAO DOCETAXEL EPIRRUBICINA; DADOS FARMACOCINETICOS

4/6US=16 / Urologia
Mohile SG, Petrylak DP. Therapeutics: taxane-based chemotherapy for prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 445-62. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

CANCER DE PROSTATA; TERAPEUTICA; TAXANO; QUIMIOTERAPIA; DOCETAXEL; ESTRAMUSTINA; PACLITAXEL; PALIACAO; RESISTENCIA; SOBREVIVENCIA; TAXANO

5/6US=120 / Câncer
Machado KK, Braghirotti MI, Rêgo JFM, Hoff PMG. Agentes antimicrotúbulos. In: Hoff PMG. Tratado de oncologia. São Paulo: Atheneu, 2013. p. 767-777. ISBN 85-388-0312-6.

ALCALOIDES DA VINCA; TAXANO; DOCETAXEL; FOSFATO DE ESTRAMUSTINA; EPOTILONAS

6/6US=736 / Tese/FAP
Mello JBH. Investigação de marcadores de resposta a quimioterapia neoadjuvante em pacientes com carcinoma de orofaringe. [Use of PET-SCAN as a predictor of efficacy for locoregional control and survival in head and neck carcinoma]. São Paulo, 2019. 127 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2019/JBHMello/JBHMello.pdf

Curriculum Lattes

NEOPLASIAS OROFARINGEAS; NEOPLASIAS DE CABECA E PESCOCO; TERAPIA NEOADJUVANTE; QUIMIOTERAPIA DE INDUCAO; CARCINOMA DE CELULAS ESCAMOSAS; BIOMARCADORES TUMORAIS